ARTL
Artelo Biosciences
$1.01
−$0.01 (−0.98%)Jul 27, 2026
Key metrics
The numbers that frame ARTL today
- Market cap
- $2.36M
- P/E (TTM)
- -0.2
- EV / FCF
- 0.9
- ROIC
- 324.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.97
- 52wk High
- $42.81
Growth
Revenue and earnings trend for ARTL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARTL
Is Artelo Biosciences a good buy?
No. Artelo Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of ARTL?
Artelo Biosciences's market capitalization is $2.36M.
What is the P/E ratio for ARTL stock?
Artelo Biosciences's current P/E ratio is -0.2.
What is the 52-week high for ARTL stock?
The 52-week high for Artelo Biosciences is $42.81. The current close of $1.01 is 97.6% below that high.
What is the 52-week low for ARTL stock?
The 52-week low for Artelo Biosciences is $0.97. The current close of $1.01 is 4.1% above that low.
Does ARTL stock pay dividends?
Artelo Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARTL?
Artelo Biosciences's Debt / Equity ratio is 0.11.